Literature DB >> 29310816

The clinical characteristics of adult bacterial meningitis caused by non-Pseudomonas (Ps.) aeruginosa Pseudomonas species: A clinical comparison with Ps. aeruginosa meningitis.

Chi-Ren Huang1, Chia-Yi Lien1, Wan-Chen Tsai1, Wei-An Lai2, Che-Wei Hsu1, Nai-Wen Tsai1, Chiung-Chih Chang1, Cheng-Hsien Lu1, Chun-Chih Chien3, Wen-Neng Chang4.   

Abstract

Adult bacterial meningitis (ABM) caused by non-Pseudomonas (Ps.) aeruginosa Pseudomonas (NPAP) species infection has rarely been reported. The clinical characteristics of 52 cases of Pseudomonas ABM (11 NPAP- and 41 Ps. aeruginosa-related meningitis) collected during a 30-year study period (1986-2015) were included. Eleven cases of NPAP ABM were identified in the literature, and their clinical data were also collected. Therefore, a total of 22 NPAP ABM cases were enrolled. The clinical characteristics of the NPAP ABM and Ps. aeruginosa ABM groups were compared. Of the implicated NPAP strains, Ps. putida and Ps. stutzeri were the most common (7 cases each), followed by Ps. mendocina in 4, Ps. fluorescens in 1, Ps. fulva in 1, Ps. alcaligenes in 1, and Ps. mosselii in 1. Of the 22 cases, 50% (11/22) had an underlying postneurosurgical state. Fever (77.3%, 17/22) and altered consciousness (45.5%, 10/22) were the most common clinical presentations. Antibiotic non-susceptibility was found in 3 strains of Ps. putida and 1 Ps. mosselii strain. Compared to the patients with Ps. aeruginosa ABM, those with NPAP ABM had a higher incidence of spontaneous infections and a better survival rate. In conclusion, although Ps. putida, Ps. stutzeri and Ps. mendocina were the major implicated strains of NPAP ABM, the clinical characteristics of this specific group of ABM demonstrated marked heterogeneity. Even though the cases with NPAP ABM had better therapeutic results than those with Ps. aeruginosa ABM, further large-scale studies are needed to better delineate this specific group of ABM.
Copyright © 2017. Published by Elsevier Taiwan.

Entities:  

Keywords:  Adult bacterial meningitis; Non-Pseudomonas aeruginosa Pseudomonas; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2017        PMID: 29310816     DOI: 10.1016/j.kjms.2017.08.007

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  7 in total

1.  CRISPR/Cas9-Mediated Genome Editing for Pseudomonas fulva, a Novel Pseudomonas Species with Clinical, Animal, and Plant-Associated Isolates.

Authors:  Nan Zhang; Jintao He; Abrar Muhammad; Yongqi Shao
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

2.  Whole-Genome Sequencing-Based Re-Identification of Pseudomonas putida/fluorescens Clinical Isolates Identified by Biochemical Bacterial Identification Systems.

Authors:  Mari Tohya; Kanae Teramoto; Shin Watanabe; Tomomi Hishinuma; Masahito Shimojima; Miho Ogawa; Tatsuya Tada; Yoko Tabe; Teruo Kirikae
Journal:  Microbiol Spectr       Date:  2022-04-07

3.  A Genome Model to Explain Major Features of Neurodevelopmental Disorders in Newborns.

Authors:  Bernard Friedenson
Journal:  Biomed Inform Insights       Date:  2019-07-31

4.  Pseudomonas mendocina Urinary Tract Infection: A Case Report and Literature Review.

Authors:  Thy Vo; Nodari Maisuradze; David Maglakelidze; Tanisha Kalra; Isabel M McFarlane
Journal:  Cureus       Date:  2022-03-28

Review 5.  Pseudomonas fluorescens Complex and Its Intrinsic, Adaptive, and Acquired Antimicrobial Resistance Mechanisms in Pristine and Human-Impacted Sites.

Authors:  Myllena Pereira Silverio; Gabriela Bergiante Kraychete; Alexandre Soares Rosado; Raquel Regina Bonelli
Journal:  Antibiotics (Basel)       Date:  2022-07-22

Review 6.  A Systematic Review of Human Infections by Pseudomonas mendocina.

Authors:  Petros Ioannou; Georgios Vougiouklakis
Journal:  Trop Med Infect Dis       Date:  2020-05-03

7.  Pseudomonas Mendocina Bacteremia in a Hemodialysis Patient With a Central Venous Catheter.

Authors:  Madeline E Goldberg; Michelle Blyth; Ed Swiatlo
Journal:  Cureus       Date:  2020-10-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.